Hypoxic condition enhances chondrogenesis in synovium-derived mesenchymal stem cells
Source abstract
Abstract
Abstract Background The chondrogenic differentiation of mesenchymal stem cells (MSCs) is regulated by many factors, including oxygen tensions, growth factors, and cytokines. Evidences have suggested that low oxygen tension seems to be an important regulatory factor in the proliferation and chondrogenic differentiation in various MSCs. Recent studies report that synovium-derived mesenchymal stem cells (SDSCs) are a potential source of stem cells for the repair of articular cartilage defects. But, the effect of low oxygen tension on the proliferation and chondrogenic differentiation in SDSCs has not characterized. In this study, we investigated the effects of hypoxia on proliferation and chondrogenesis in SDSCs. Method SDSCs were isolated from patients with osteoarthritis at total knee replacement. To determine the effect of oxygen tension on proliferation and colony-forming characteristics of SDSCs, A colony-forming unit (CFU) assay and cell counting-based proliferation assay were performed under normoxic (21% oxygen) or hypoxic (5% oxygen). For in vitro chondrogenic differentiation, SDSCs were concentrated to form pellets and subjected to conditions appropriate for chondrogenic differentiation under normoxia and hypoxia, followed by the analysis for the expression of genes and proteins of chondrogenesis. qRT-PCR, histological assay, and glycosoaminoglycan assays were determined to assess chondrogenesis. Results Low oxygen condition significantly increased proliferation and colony-forming characteristics of SDSCs compared to that of SDSCs under normoxic culture. Similar pellet size and weight were found for chondrogensis period under hypoxia and normoxia condition. The mRNA expression of types II collagen, aggrecan, and the transcription factor SOX9 was increased under hypoxia condition. Histological sections stained with Safranin-O demonstrated that hypoxic conditions had increased proteoglycan synthesis. Immunohistochemistry for types II collagen demonstrated that hypoxic culture of SDSCs increased type II collagen expression. In addition, GAG deposition was significantly higher in hypoxia compared with normoxia at 21 days of differentiation. Conclusion These findings show that hypoxia condition has an important role in regulating the synthesis ECM matrix by SDSCs as they undergo chondrogenesis. This has important implications for cartilage tissue engineering applications of SDSCs.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Mesenchymal stem cell research · Proteoglycans and glycosaminoglycans research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Orthopedic Surgery, Seoul National University Hospital, Yongondong Chongnogu, Seoul 110-744, Republic of Korea.
Funding
Seoul National University Hospital
References (35)
Show source-provided references
1. Pastides P, Chimutengwende-Gordon M, Maffulli N, Khan W. Stem cell therapy for human cartilage defects: a systematic review. Osteoarthr Cartil. 2013;21:646–654. 1:STN:280:DC%2BC3svlsVKrtw%3D%3D10.1016/j.joca.2013.02.008 ↗
2. 10.1186/s13075-014-0432-110.1186/s13075-014-0432-1 ↗
3. 10.1002/art.2121210.1002/art.21212 ↗
4. Kubosch EJ, Lang G, Furst D, Kubosch D, Izadpanah K, Rolauffs B, Sudkamp NP, Schmal H. The potential for synovium-derived stem cells in cartilage repair. Curr Stem Cell Res Ther. 2018;13:174–184. 1:CAS:528:DC%2BC1cXjs1egt7s%3D10.2174/1574888X12666171002111026 ↗
5. Yusuke O, Yo M, Mayu Y, Eriko GS, Nobuharu S, Takeshi M, Ichiro S, Chihiro A. Purified human synovium mesenchymal stem cells as a good resource for cartilage regeneration. PLoS One. 2015;10
6. Danišoviča L, Varga I, Polákc S. Growth factors and chondrogenic differentiation of mesenchymal stem cells. Tissue Cell. 2012;44:69–73.10.1016/j.tice.2011.11.005 ↗
7. Rodrigo AS, Jean FW, Diego C, Arnold IC. Chondrogenic differentiation of mesenchymal stem cells: challenges and unfulfilled expectations. Tissue Eng Part B Rev. 2014;20:596–608.10.1089/ten.teb.2013.0771 ↗
8. Chiou SH, et al. Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor. PLoS One. 2008;310.1371/journal.pone.0002090 ↗
9. 10.1089/ten.teb.2009.029610.1089/ten.teb.2009.0296 ↗
10. Kim DS, et al. Effect of low oxygen tension on the biological characteristics of human bone marrow mesenchymal stem cells. Cell Stress Chaperones. 2016;21:1089–1099. 1:CAS:528:DC%2BC28XhsVamsrjF10.1007/s12192-016-0733-1 ↗
11. 10.5966/sctm.2014-018010.5966/sctm.2014-0180 ↗
12. Roy S, Tripathy M, Mathur N, Jain A, Mukhopadhyay A. Hypoxia improves expansion potential of human cord blood-derived hematopoietic stem cells and marrow repopulation efficiency. Eur J Haematol. 2012;88:396–405. 1:CAS:528:DC%2BC38XptVGlsLc%3D10.1111/j.1600-0609.2012.01759.x ↗
13. 10.1111/j.1365-2613.2010.00707.x10.1111/j.1365-2613.2010.00707.x ↗
14. Fermor B, Christensen SE, Youn I, Cernanec JM, Davies CM, Weinberg JB. Oxygen, nitric oxide and articular cartilage. Eur Cell Mater. 2007;13:56–65. 1:CAS:528:DC%2BD2sXmsVOrtr8%3D10.22203/eCM.v013a06 ↗
15. Lafont JE, Talma S, Murphy CL. Hypoxia-inducible factor 2alpha is essential for hypoxic induction of the human articular chondrocyte phenotype. Arthritis Rheum. 2007;56:3297–3306. 1:CAS:528:DC%2BD2sXht12rtLnE10.1002/art.22878 ↗
16. Shang J, Liu H, Li J, Zhou Y, Fermor B, Gimble JM, Awad HA, Guilak F. Roles of hypoxia during the chondrogenic differentiation of mesenchymal stem cells. Curr Stem Cell Res Ther. 2014;9:141–147. 1:CAS:528:DC%2BC2cXhvVWlu74%3D10.2174/1574888X09666131230142459 ↗
17. Scherer K, Schunke M, Sellckau R, Hassenpflug J, Kurz B. The influence of oxygen and hydrostatic pressure on articular chondrocytes and adherent bone marrow cells in vitro. Biorheology. 2004;41:323–333. 1:CAS:528:DC%2BD2cXlvF2iur8%3D
18. Lee S, Kim JH, Jo CH, Seong SC, Lee JC, Lee MC. Effect of serum and growth factors on chondrogenic differentiation of synoviumderived stromal cells. Tissue Eng Part A. 2009;15(11):3401–3415. 1:CAS:528:DC%2BD1MXhsF2iu7bI10.1089/ten.tea.2008.0466 ↗
19. 10.1053/joca.2002.080110.1053/joca.2002.0801 ↗
20. Lee JW, Kim YH, Kim SH, Han SH, Hahn SB. Chondrogenic differentiation of mesenchymal stem cells and its clinical applications. Yonsei Med J. 2004;45(Suppl):41–47.10.3349/ymj.2004.45.Suppl.41 ↗
21. Kadiyala S, Young RG, Thiede MA, Bruder SP. Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant. 1997;6(2):125–134. 1:STN:280:DyaK2s3oslemsA%3D%3D10.1177/096368979700600206 ↗
22. Meirelles Lda S, Nardi NB. Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br J Haematol. 2003;123(4):702–711.10.1046/j.1365-2141.2003.04669.x ↗
23. Fan J, Varshney RR, Ren L, Cai D, Wang DA. Synovium-derived mesenchymal stem cells: a new cell sourcefor musculoskeletal regeneration. Tissue Eng Part B Rev. 2009;15:75. 1:CAS:528:DC%2BD1MXivVKisrw%3D10.1089/ten.teb.2008.0586 ↗
24. 10.1002/bdrc.1001510.1002/bdrc.10015 ↗
25. Kim JH, Lee MC, Seong SC, Park KH, Lee S. Enhanced proliferation and chondrogenic differentiation of human synovium-derived stem cells expanded with basic fibroblast growth factor. Tissue Eng Part A. 2011;17:991. 1:CAS:528:DC%2BC3MXjsFOgtb0%3D10.1089/ten.tea.2010.0277 ↗
26. Kanichai M, Ferguson D, Prendergast PJ, Campbell VA. Hypoxia promotes chondrogenesis in rat mesenchymal stem cells: a role for AKT and hypoxia-inducible factor (HIF)-1alpha. J Cell Physiol. 2008;216(3):708–715. 1:CAS:528:DC%2BD1cXhtVSisrvK10.1002/jcp.21446 ↗
27. Khan WS, Adesida AB, Tew SR, Lowe ET, Hardingham TE. Bone marrow-derived mesenchymal stem cells express the pericyte marker 3G5 in culture and show enhanced chondrogenesis in hypoxic conditions. J Orthop Res. 2010;28(6):834–840. 1:CAS:528:DC%2BC3cXmsVGks7g%3D10.1002/jor.21043 ↗
28. Khan WS, Adesida AB, Hardingham TE. Hypoxic conditions increase hypoxia-inducible transcription factor 2α and enhance chondrogenesis in stem cells from the infrapatellar fat pad of osteoarthritis patients. Arthritis Research & Therapy. 2007;9:R55.10.1186/ar2211 ↗
29. Baumgartner L, Arnhold S, Brixius K, Addicks K, Bloch W. Human mesenchymal stem cells: influence of oxygen pressure on proliferation and chondrogenic differentiation in fibrin glue in vitro. J Biomed Mater Res A. 2010;93(3):930–940.10.1002/jbm.a.32577 ↗
30. Werb Z, Chin JR. Extracellular matrix remodelling during morphogenesis. Ann N Y Acad Sci. 1998;857:110–118. 1:CAS:528:DyaK1cXns1Gqurw%3D10.1111/j.1749-6632.1998.tb10111.x ↗
31. 10.1046/j.1432-1033.2003.03846.x10.1046/j.1432-1033.2003.03846.x ↗
32. 10.1074/jbc.275.19.1413910.1074/jbc.275.19.14139 ↗
33. 10.1006/meth.2001.126210.1006/meth.2001.1262 ↗
34. Shang J, Liu H, Li J, Zhou Y. Roles of hypoxia during the Chondrogenic differentiation of mesenchymal stem cells. Methods. 2014;9:141–147. 1:CAS:528:DC%2BC2cXhvVWlu74%3D
35. Han H-S, Lee S, Kim JH, Seong SC, Lee MC. Changes in Chondrogenic phenotype and gene expression profiles associated with the in vitro expansion of human synovium-derived cells. J Orthop Res. 2010;28:1283–1291. 1:CAS:528:DC%2BC3cXhtF2rtrvE10.1002/jor.21129 ↗